Strategia Therapeutics Initiates a Phase 1 Clinical Trial of the Anti-cancer …

Strategia Therapeutics Initiates a Phase 1 Clinical Trial of the Anti-cancer …

Strategia Therapeutics (Strategia), a primary global strategic drug development provider for FUJIFILM Pharmaceuticals U.S.A., Inc. (FPHU), has initiated a Phase 1 clinical trial of FUJIFILM's anti-cancer agent FF-10502 in the United States in patients

(Visited 4 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.